Clinical Trial Update: Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates aspirin as an add-on treatment for refractory epilepsy in tuberous sclerosis complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Tuberous Sclerosis Complex

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Tuberous Sclerosis Complex, Aspirin | Phase 2 | Status: UNKNOWN